Teach me: Monitoring parameters Hemodynamic goals Electrolyte management Complications Escalation of care 11. Guidelines & Protocols Always include: Latest evidence-based guidelines Standard treatment protocols OPD protocol Ward protocol ICU protocol Emergency protocol Mention major guideline sources whenever possible. 12. Complications Explain: Early complications Late complications Prevention Management 13. Clinical Pearls Provide: High-yield MBBS exam points Practical bedside pearls Common mistakes made by students Frequently asked viva questions 14. Case-Based Learning Create: OPD case scenario Ward case scenario ICU case scenario Ask me questions and help me reason through the diagnosis and management. 15. Visual Learning Whenever possible, use: Tables Flowcharts Algorithms Mnemonics Mind maps Summary sheets 16. Safety Rule Never give unsafe medical advice. Always clearly distinguish: Educational learning Real-world clinical decision making When discussing treatments, indicate when supervision by a qualified physician is required. My goal is not just to pass exams but to think and manage patients like a competent junior doctor with strong foundations in physiology, pathology, diagnosis, prescription writing, emergency medicine, and ICU management.

Asking for Preferences
Asking for Preferences
Reading File
Finding Sources
Searching PubMed

"sepsis"[MeSH Terms] AND "septic shock"[MeSH Terms]

Searching the Web

Surviving Sepsis Campaign 2024 guidelines summary

Reading File
Reading File
Reading File
Reading Web Page

sepsis management guidelines 2026 recommendations

Reading File
Reading File
Finding Sources
Loading Image
Reading File
I now have rich, comprehensive content from Harrison's 22E (2025), Barash 9E, Rosen's EM, and the SSC 2026 guidelines. I have everything needed to write the full teaching module. Let me now compose the complete, structured response.

Note: Since you skipped topic selection, I've chosen Sepsis and Septic Shock - the single most important topic for MBBS/junior doctor training. It covers every domain you requested: ICU protocols, hemodynamics, electrolytes, emergencies, guidelines, and clinical reasoning. If you wanted a different topic, just tell me and I'll rebuild it.

SEPSIS & SEPTIC SHOCK

Complete Clinical Teaching Module for Junior Doctors

Sources: Harrison's Principles of Internal Medicine 22E (2025) | Barash Clinical Anesthesia 9E | Rosen's Emergency Medicine 9E | Goldman-Cecil Medicine | SSC Guidelines 2026

PART 1 - DEFINITION & EPIDEMIOLOGY

Sepsis-3 Definitions (2016 - Current Standard)

TermDefinitionClinical Criteria
InfectionPathologic process caused by invasion of normally sterile tissue by organismsClinical suspicion + culture/imaging
SepsisLife-threatening organ dysfunction caused by dysregulated host response to infectionSOFA score increase ≥ 2 points
Septic ShockSepsis + circulatory/cellular/metabolic abnormalities severe enough to substantially increase mortalityVasopressor requirement to maintain MAP ≥65 mmHg + serum lactate >2 mmol/L despite adequate fluid resuscitation
Mortality: Sepsis ~10-15%, Septic Shock ~40%. Importantly, sepsis mortality has been declining (19% in 2009 to ~15% in 2014) despite stable incidence - attributed to protocol-driven care.
Sepsis incidence and mortality trends 2009-2014
Sepsis incidence (~5-6% of hospitalizations) vs. sepsis mortality (declining, ~15-19%) - Harrison's 22E
Why was SIRS abandoned? The old Sepsis-1/2 criteria (fever, tachycardia, tachypnea, leukocytosis) were too non-specific. Many non-infected patients met SIRS. SOFA-based Sepsis-3 focuses on organ dysfunction, which is what kills patients.

PART 2 - PATHOPHYSIOLOGY (The "Why" Behind Every Treatment)

INFECTION
    ↓
Pathogen Recognition (TLRs, NLRs, pattern recognition receptors)
    ↓
Activated myeloid cells (neutrophils, macrophages, monocytes)
    ↓
Cytokine storm: TNF-α, IL-1, IL-6, IL-8
    ↓
┌─────────────────────────────────────────────────┐
│  Endothelial damage → capillary leak → edema    │
│  ↓ SVR (vasodilation) → distributive shock      │
│  Myocardial depression (septic cardiomyopathy)  │
│  Microvascular thrombosis → DIC                 │
│  Mitochondrial dysfunction → lactic acidosis    │
└─────────────────────────────────────────────────┘
    ↓
Multi-Organ Dysfunction Syndrome (MODS)
(Lungs: ARDS | Kidneys: AKI | Brain: Encephalopathy | Liver: Cholestasis | Adrenals: Relative insufficiency)
Key physiology pearls:
  • Septic shock is distributive - high CO, low SVR (warm shock early)
  • Despite high CO, tissues cannot extract oxygen properly ("cytopathic hypoxia")
  • Lactic acidosis occurs even with normal BP due to mitochondrial failure, not just hypoperfusion
  • Late septic shock may also have myocardial depression (low CO phase)

PART 3 - DIAGNOSIS & SCORING TOOLS

SOFA Score (Sequential Organ Failure Assessment)

SystemParameter01234
RespiratoryPaO₂/FiO₂≥400300-399200-299100-199 on vent<100 on vent
CoagulationPlatelets (×10³/µL)≥150100-14950-9920-49<20
LiverBilirubin (mg/dL)<1.21.2-1.92.0-5.96.0-11.9>12
CVSMAP or vasopressorsMAP ≥70MAP <70Dopa ≤5 or DobutaDopa 5.1-15 or NE ≤0.1Dopa >15 or NE >0.1
CNSGlasgow Coma Scale1513-1410-126-9<6
RenalCreatinine (mg/dL)<1.21.2-1.92.0-3.43.5-4.9>5
SOFA ≥2 from baseline = sepsis. Score correlates with mortality.

qSOFA (Quick Bedside Screening - no labs needed)

ParameterPoints
Altered mental status (GCS <15)1
Respiratory rate ≥22/min1
Systolic BP ≤100 mmHg1
qSOFA ≥2 = high suspicion, proceed to full SOFA. Use at bedside/triage.

Common Sources of Infection (MBBS Mnemonic: LURASI)

  • Lung (pneumonia - 33%)
  • Urinary tract (UTI/urosepsis - 49%)
  • Residual (intraabdominal/gut - 14%)
  • Abdominal (bowel perforation, cholangitis)
  • Skin/soft tissue (cellulitis, wounds - 10%)
  • Intravenous line (catheter-related bloodstream infection)

PART 4 - INVESTIGATIONS

Bedside / Emergency Panel

TestWhat You're Looking For
CBCLeukocytosis (>12,000) or leukopenia (<4,000), left shift (bands ≥10%), thrombocytopenia (DIC)
Blood cultures ×2 (before antibiotics)Identify organism - positive in ~40-53% of sepsis
Lactate≥2 mmol/L = sepsis; ≥4 = high mortality; trend matters more than single value
Serum creatinine + eGFRAKI (occurs in up to 66% of septic shock patients)
LFTs + bilirubinHepatic dysfunction (SOFA component)
Coagulation (PT, aPTT, fibrinogen, D-dimer)DIC screen
Procalcitonin (PCT)Guide antibiotic de-escalation (NOT to start antibiotics - SSC 2026)
Blood glucoseHyperglycemia is common (stress response + relative insulin resistance)
ABG / VBGMetabolic acidosis, hypoxia, pH, lactate
CXR / bedside lung USSource (pneumonia, ARDS), fluid status
Urinalysis + urine cultureUrosepsis
ECGSeptic cardiomyopathy, arrhythmias
Point-of-care echo (POCUS)Volume responsiveness, LV/RV function

Electrolytes Specifically

ElectrolyteCommon Abnormality in SepsisCauseTarget
SodiumHypo or hypernatremiaFluid shifts, ADH release135-145 mEq/L
PotassiumHypokalemia (early), hyperkalemia (AKI)Stress catecholamines, renal failure3.5-5.0 mEq/L
CalciumHypocalcemia (ionized Ca²⁺ low)Albumin loss, PTH resistanceiCa >1.1 mmol/L
MagnesiumHypomagnesemiaGI losses, drugs1.8-2.4 mg/dL
PhosphateHypophosphatemiaRedistribution, refeeding2.5-4.5 mg/dL
GlucoseHyperglycemiaStress response, insulin resistance140-180 mg/dL (SSC 2026: start insulin at ≥180)
BicarbonateLow (metabolic acidosis)Lactic acidosis, AKIAddress underlying cause

PART 5 - HEMODYNAMIC GOALS & MONITORING

Hemodynamic Targets (SSC 2026 + Harrison's 22E)

ParameterTargetNotes
MAP≥65 mmHgPrimary BP target; may individualize to ≥70-75 in elderly with chronic hypertension
Lactate<2 mmol/L (or ≥10% clearance per 2h)Trend matters; target lactate clearance as resuscitation goal
CVP8-12 mmHg (mechanically ventilated: 12-15)Unreliable in isolation; use dynamic measures
ScvO₂≥70%Central venous O₂ saturation from internal jugular/subclavian CVC
Urine output≥0.5 mL/kg/hourReflects renal perfusion
Heart rate<100/min (target)Sinus tachycardia is expected; rapid rates compromise diastolic filling
SpO₂90-96%Avoid hyperoxia; target SpO₂ 94-98% if no ARDS

Dynamic Measures of Volume Responsiveness (Better than CVP)

TestHowPositive = Fluid Responsive
Passive Leg Raise (PLR)Raise legs 45° for 1 min, watch pulse pressure↑CO by >10%
Pulse Pressure Variation (PPV)Mechanically ventilated patientsPPV >13%
Stroke Volume Variation (SVV)Requires arterial line + ventilatorSVV >10-15%
IVC collapsibility (POCUS)US of IVC with respirationCollapsibility >50% = hypovolemic
Key pearl: CVP alone should NOT be used to guide fluid therapy (SSC 2026 - no longer recommended as sole guide).

Monitoring Parameters (ICU Checklist)

CONTINUOUS:
  ✓ ECG monitoring (rhythm, rate)
  ✓ SpO₂ (pulse oximetry)
  ✓ Arterial line → continuous BP, ABG access
  ✓ CVP (if CVC in place)

HOURLY:
  ✓ Urine output (Foley catheter mandatory)
  ✓ Temperature
  ✓ GCS / mental status

EVERY 2-4 HOURS:
  ✓ Lactate (until normalized)
  ✓ Glucose
  ✓ ABG (if mechanically ventilated)

DAILY:
  ✓ CBC, electrolytes, renal/hepatic function
  ✓ Coagulation (if DIC concern)
  ✓ PCT trend (antibiotic de-escalation)
  ✓ Chest X-ray
  ✓ SOFA score reassessment

PART 6 - MANAGEMENT PROTOCOLS

THE SEPSIS HOUR-1 BUNDLE (SSC 2021/2026)

This is the most exam-tested and clinically critical content. Memorize this.
Within 1 HOUR of Recognition:

1. MEASURE LACTATE → If >2 mmol/L, re-measure after resuscitation
2. BLOOD CULTURES ×2 → Before antibiotics (one peripheral + one CVC site if available)
3. ANTIBIOTICS → Broad-spectrum IV within 1 hour (septic shock) or 3 hours (sepsis)
4. IV FLUIDS → 30 mL/kg crystalloid bolus if hypotension or lactate ≥4 mmol/L
5. VASOPRESSORS → Start norepinephrine if MAP <65 despite initial fluids
Mnemonic: LBLAV
  • Lactate measure
  • Blood cultures
  • Launch antibiotics
  • Administer fluids
  • Vasopressors if needed

FLUID RESUSCITATION

PhaseGoalFluid ChoiceVolume
Rescue (0-1h)Restore perfusionCrystalloid (Normal Saline or Lactated Ringer's)30 mL/kg bolus
Optimization (1-6h)Meet hemodynamic targetsCrystalloid; albumin if large volumes givenGuided by dynamic measures
Stabilization (6-24h)Maintain organ functionConservative approach; avoid over-resuscitationMaintain MAP, UO
De-escalation (>24h)Remove excess fluidActive diuresis if overloadedNet negative fluid balance
SSC 2026 key recommendation: For patients with septic shock NOT responding to initial fluids, start vasopressors EARLY rather than giving more fluid. Use balanced crystalloids (Lactated Ringer's) over normal saline to reduce hyperchloremic acidosis and AKI.
Why NOT colloids (HES)? Hydroxyethyl starch (HES) increases risk of AKI and mortality in sepsis - absolutely contraindicated.

VASOPRESSOR PROTOCOL (SSC 2026)

STEP 1: Norepinephrine (NE) → FIRST-LINE
  Dose: 0.01-3.3 mcg/kg/min IV infusion
  Start at: 0.01-0.05 mcg/kg/min, titrate to MAP ≥65
  
  ↓ If MAP still <65 at moderate NE dose:
  
STEP 2: ADD Vasopressin 0.03-0.04 units/min (fixed dose, do NOT titrate)
  - Spares NE dose
  - May reduce AKI risk
  
  ↓ If still not at goal:
  
STEP 3: ADD Epinephrine
  - Use when cardiac dysfunction coexists
  - Increases HR, contractility, AND vasoconstriction
  
SPECIAL:
  Dobutamine → Add to NE if myocardial dysfunction (low CO + evidence of hypoperfusion)
  Angiotensin II → Considered for refractory vasodilatory shock
  
AVOID:
  ✗ Dopamine as first-line (higher arrhythmia risk vs. NE - SSC 2026)
  ✗ Phenylephrine in septic shock (decreases CO)

ANTIBIOTIC PROTOCOL

SituationEmpiric Regimen (First Choice)
Unknown source, community-acquiredPiperacillin-tazobactam 4.5g IV q6h + Vancomycin 25-30 mg/kg IV load
Pneumonia (CAP-origin sepsis)Ceftriaxone 2g IV OD + Azithromycin 500mg IV/PO
Urosepsis (community)Ceftriaxone 2g IV OD (culture first)
Hospital-acquired / ICU / MDRO riskMeropenem 1g IV q8h + Vancomycin (if MRSA risk)
Neutropenic sepsisPiperacillin-tazobactam 4.5g IV q6h or Ceftazidime 2g IV q8h
Abdominal sourcePiperacillin-tazobactam OR Meropenem + Metronidazole 500mg IV q8h
Fungal risk (immunocompromised, prolonged ICU)Add Fluconazole 400mg IV or Micafungin
De-escalation principle: Narrow antibiotics based on culture results (SSC 2026). Use PCT trends to guide stopping antibiotics (not starting them).

CORTICOSTEROIDS

Indication: Septic shock requiring ongoing vasopressor therapy despite adequate fluid resuscitation.
  • Drug: Hydrocortisone 200 mg/day IV (50 mg q6h OR 200 mg continuous infusion)
  • Do NOT use dexamethasone (suppresses HPA axis cortisol testing)
  • ACTH stimulation test NOT required before starting
  • Duration: Until vasopressors weaned
  • Mechanism: Relative adrenal insufficiency in ~50% of septic shock patients; steroid restores vascular responsiveness to catecholamines

BLOOD GLUCOSE MANAGEMENT

Glucose LevelAction
<140 mg/dLNo insulin needed
140-180 mg/dLMonitor closely, consider insulin
≥180 mg/dLStart insulin infusion (SSC 2026 - Strong recommendation)
Target range140-180 mg/dL (avoid hypoglycemia)
Never target normoglycemia (<110 mg/dL) - the NICE-SUGAR trial showed increased mortality with tight glucose control.

PART 7 - ESCALATION OF CARE

When to Escalate from Ward to ICU

CriterionAction
MAP <65 despite 1-2L fluidICU / HDU - vasopressors needed
Lactate >4 mmol/LICU urgently
SpO₂ <90% despite high-flow O₂ICU - may need NIV/intubation
GCS deteriorationICU
Oliguria <0.5 mL/kg/h for >2hEscalate
SOFA score increasingEscalate
Respiratory rate >30/minEscalate
Hemodynamic instability despite initial bundleICU

Respiratory Escalation Algorithm

Hypoxemia in Sepsis
        ↓
SpO₂ <94% → Nasal cannula 2-6 L/min
        ↓ if inadequate
Simple face mask 6-10 L/min
        ↓ if inadequate
Non-rebreather mask 10-15 L/min
        ↓ if inadequate
HIGH-FLOW NASAL CANNULA (HFNC) - preferred over NIV (SSC 2026)
  Flow: 40-60 L/min | FiO₂ titrated
        ↓ if SpO₂ <90% or WOB ↑
INTUBATION + MECHANICAL VENTILATION
  (Lung-protective: Vt 6 mL/kg IBW, Plateau P <30 cmH₂O)
        ↓ if refractory (PaO₂/FiO₂ <150)
PRONE POSITIONING (16 hours/day)
NEUROMUSCULAR BLOCKADE
VV-ECMO (tertiary center)

PART 8 - COMPLICATIONS

Early Complications (First 24-72 Hours)

ComplicationMechanismSignsManagement
ARDS (7% of sepsis)Cytokine-mediated alveolar damage, capillary leakBilateral infiltrates, PaO₂/FiO₂ <300, hypoxiaLung-protective ventilation, prone positioning
AKI (up to 66%)Renal hypoperfusion, microvascular injury, nephrotoxins↑Cr, oliguriaOptimize MAP, hold NSAIDs/contrast, avoid aminoglycosides
DICWidespread endothelial activation, thrombin generationThrombocytopenia, ↑PT/aPTT, ↓fibrinogen, ↑D-dimer, bleedingTreat cause; FFP if bleeding; platelets if <50k and bleeding
Hepatic dysfunctionHypoperfusion + direct cytokine injury↑bilirubin, ↑transaminasesSupportive; avoid hepatotoxins
Septic cardiomyopathyTNF-α, IL-1 induced myocardial depressionLow CO, low EF on ECHODobutamine; consider epinephrine
Lactic acidosisAnaerobic metabolism + mitochondrial dysfunctionpH <7.35, lactate >4Treat underlying sepsis; avoid sodium bicarbonate unless pH <7.1
Adrenal crisisRelative adrenal insufficiencyRefractory hypotensionHydrocortisone 200 mg/day

Late Complications (After Acute Phase)

ComplicationNotes
Post-sepsis syndrome (PICS)Physical weakness, cognitive impairment, depression - seen in >50% of survivors
ICU-acquired weakness (ICUAW)Muscle atrophy, critical illness polyneuropathy/myopathy
Chronic kidney diseaseAKI that does not fully recover
Psychological PTSDEspecially after prolonged ICU stay
Recurrent infectionsImmune suppression post-sepsis ("immunoparalysis")
Hospital-acquired infectionsVAP, CLABSI, CAUTI - from ICU devices

Prevention of Complications

DIC/Bleeding: Early antibiotics + source control
AKI: Maintain MAP ≥65, avoid nephrotoxins, balanced crystalloids
VAP: Head-of-bed elevation 30-45°, daily sedation holds, early extubation
DVT/PE: Pharmacological VTE prophylaxis (heparin) - SSC 2026 recommends pharmacologic alone
Stress ulcer: Proton pump inhibitor (consider if on mechanical ventilation)
ICUAW: Early physiotherapy, minimize sedation

PART 9 - PROTOCOLS BY SETTING

OPD Protocol (Walk-In Patient with Possible Sepsis)

Patient presents with fever + altered general condition

STEP 1: SCREEN (2 min)
  - Check qSOFA: Altered sensorium? RR ≥22? SBP ≤100?
  - Temp, HR, BP, SpO₂, RR at triage

STEP 2: TRIAGE DECISION
  qSOFA 0-1 + hemodynamically stable:
    → Blood work (CBC, CRP, cultures), urine culture
    → Oral antibiotics if bacterial infection confirmed
    → Return precautions clearly explained
    → Follow-up in 24h
    
  qSOFA ≥2 OR SBP <90 OR any organ dysfunction:
    → DO NOT discharge → Call ambulance / transfer to ED immediately
    → IV access en route
    → O₂ supplementation

⚠️ SAFETY RULE: Never send a septic patient home with oral antibiotics if they have
evidence of organ dysfunction. This requires hospital admission.

Ward Protocol (Admitted Patient Developing Sepsis)

Ward patient → Nurse notices: fever spike + tachycardia + confusion

STEP 1: RAPID ASSESSMENT (0-15 min)
  → Vital signs Q15 min
  → GCS, urine output check
  → IV access (large bore ×2)
  → O₂ via face mask, SpO₂ monitor

STEP 2: INVESTIGATIONS (simultaneous)
  → Blood cultures ×2 (BEFORE antibiotics)
  → CBC, metabolic panel, lactate, coagulation
  → CXR (portable)
  → Urinalysis + culture
  → ECG

STEP 3: CALL DOCTOR + IMPLEMENT
  → Notify registrar/consultant IMMEDIATELY
  → 30 mL/kg crystalloid bolus over 30-60 min (if not contraindicated)
  → Broad-spectrum antibiotics WITHIN 1 HOUR
  → Catheterize (urine output monitoring)

STEP 4: REASSESS (1h mark)
  → MAP <65 despite fluids → Transfer to HDU/ICU, start vasopressors
  → Lactate not clearing → ICU
  → SpO₂ <90% → Escalate O₂, ICU referral
  → Response to treatment → Continue ward management with close monitoring

ICU Protocol (Septic Shock Patient)

ICU ADMISSION CHECKLIST:
  □ Arterial line (continuous BP + ABG access)
  □ Central venous catheter (CVC) - right internal jugular or subclavian
  □ Foley catheter (hourly urine output)
  □ NGT (nutrition)
  □ Continuous ECG + SpO₂
  □ Point-of-care ECHO (assess volume status, LV function)

BUNDLE COMPLIANCE AUDIT (Hour 1):
  □ Lactate measured?
  □ Blood cultures × 2 drawn?
  □ Broad-spectrum antibiotics given?
  □ 30 mL/kg fluid given?
  □ Vasopressors started if MAP <65?

ONGOING ICU MANAGEMENT:
  □ Vasopressor titration to MAP ≥65
  □ Lactate q2h until <2 mmol/L
  □ Glucose monitoring q1-2h (target 140-180 mg/dL)
  □ Electrolyte correction (K⁺, Mg²⁺, Ca²⁺, PO₄)
  □ Lung-protective ventilation if intubated (Vt 6 mL/kg IBW)
  □ Daily sedation hold + SAT/SBT protocol
  □ VTE prophylaxis (heparin 5000 U SC q8-12h)
  □ Stress ulcer prophylaxis (PPI)
  □ Early enteral nutrition (within 24-48h, SSC 2026: within 72h)
  □ Daily SOFA score recalculation
  □ Antibiotic de-escalation based on cultures + PCT trend
  □ Source control (drain abscess, remove infected catheter)

Emergency Protocol (ED Presentation)

CODE SEPSIS - Activation Criteria:
  Suspected infection + ≥2 of: Temp >38.3 or <36°C | HR >90 | RR >20 | Altered sensorium

TIME ZERO (Recognition):
  0 min: Two large-bore IVs | O₂ | Monitor | Glucose check
  5 min: Blood cultures ×2 | Lactate | CBC | CMP | Coag
  15 min: CXR (portable) | ECG | UA | IV fluids RUNNING
  30 min: Antibiotics IN (don't wait for culture results)
  60 min: Reassess MAP + lactate
           ↓ If MAP <65 → Vasopressors (NE via CVC or peripheral large bore)
           ↓ If SpO₂ <90% → HFNC or NIV
           ↓ If GCS declining → RSI + intubation

DOCUMENTATION: Time of recognition, time of antibiotics, time of cultures, 
  fluid volumes, vasopressor start time (medicolegal and audit purposes)

PART 10 - GUIDELINES & SOURCES

GuidelineYearKey Points
Surviving Sepsis Campaign (SSC) 2026March 2026129 recommendations; 46 new statements; emphasizes early vasopressors, balanced crystalloids, antibiotic stewardship, post-ICU care
SSC 2021Oct 2021Hour-1 bundle; HFNC preferred over NIV; restrictive RBC transfusion
Sepsis-3 Consensus2016SOFA-based definitions, removed SIRS criteria
NICE-SUGAR Trial2009No tight glucose control; target 140-180 mg/dL
PROCESS / ARISE / ProMISe Trials2014-2015EGDT not superior to usual care; simplified bundle
SMART Trial2018Balanced crystalloids (LR) reduce AKI vs NS
VASST Trial2008Vasopressin as NE-sparing agent in moderate shock
APROCCHSS Trial2018Hydrocortisone + fludrocortisone reduce mortality in septic shock
REMAP-CAPOngoingPlatform trial addressing multiple sepsis interventions

PART 11 - CLINICAL PEARLS FOR EXAMS & VIVA

High-Yield MBBS Exam Points

  1. Sepsis-3 definition: Sepsis = infection + SOFA ≥2; Septic shock = sepsis + vasopressor + lactate >2 despite fluids
  2. Most common source: Urinary tract (48.9%) followed by respiratory (32.9%)
  3. Most common organisms: Gram+ = S. aureus, Streptococcus; Gram- = E. coli, Klebsiella, Pseudomonas
  4. First-line vasopressor: Norepinephrine (NOT dopamine - SSC 2026)
  5. Fluid of choice: Balanced crystalloid (Lactated Ringer's > Normal Saline)
  6. NEVER give HES (hydroxyethyl starch) - increases mortality
  7. Glucose target: 140-180 mg/dL (not normal range - NICE-SUGAR)
  8. Corticosteroids: Only if vasopressor-dependent; Hydrocortisone 200 mg/day
  9. Antibiotics: WITHIN 1 hour in septic shock; don't wait for culture results
  10. Septic shock mortality: ~40-50% despite treatment

Common Student Mistakes

MistakeCorrect Approach
Waiting for cultures before giving antibioticsCultures take 5 min to draw, then start antibiotics immediately
Using dopamine as first vasopressorNorepinephrine is first-line (dopamine has higher arrhythmia risk)
Targeting tight glucose controlTarget 140-180, not <110
Giving HES/colloidOnly crystalloids (and albumin in specific situations)
Using CVP alone to guide fluidsUse dynamic measures (PLR, PPV, IVC US)
Stopping antibiotics when fever resolvesUse PCT trend + clinical improvement for de-escalation
Not doing blood cultures before antibioticsAlways cultures first (takes only minutes)
Not doing source controlRemove infected catheters, drain abscesses

Frequently Asked Viva Questions

  1. "What is the difference between Sepsis-2 and Sepsis-3?"
    • Sepsis-2 used SIRS criteria (too non-specific). Sepsis-3 uses SOFA score (organ dysfunction focused) and eliminated "severe sepsis" as a term.
  2. "Why is lactate important in sepsis?"
    • Lactate >2 mmol/L = tissue hypoperfusion; Lactate >4 = very high mortality. Used for diagnosis of septic shock (even with normal BP) and as a resuscitation endpoint (target clearance). Limitation: liver/kidney failure can impair clearance.
  3. "What is qSOFA and when do you use it?"
    • Quick bedside screen (no labs): altered sensorium + RR ≥22 + SBP ≤100. Score ≥2 = high risk. Use in wards/ED triage, not in ICU.
  4. "Why not use dopamine in septic shock?"
    • Higher risk of atrial fibrillation and arrhythmias vs. norepinephrine. A 2012 meta-analysis showed dopamine associated with higher 28-day mortality. NE is cleaner, predictable, and preferred.
  5. "What is relative adrenal insufficiency?"
    • In septic shock, the adrenal glands may produce insufficient cortisol for the degree of stress, even if absolute cortisol levels are "normal." Results in catecholamine-refractory vasodilation. Treated with hydrocortisone.

PART 12 - CASE-BASED LEARNING

I'll ask you to work through these - respond with your answers and I'll guide you:

CASE 1 - OPD Scenario

A 65-year-old man with Type 2 Diabetes comes to your OPD with 2 days of burning micturition, fever (38.8°C), chills, and since this morning he has been "confused." His wife says he is "not himself." He has no prior cardiac or renal disease.
Vitals: BP 88/54 mmHg | HR 118/min | RR 24/min | Temp 38.8°C | SpO₂ 95% on room air | Random glucose 234 mg/dL
Questions for you to answer:
  1. Calculate his qSOFA score. What does it mean?
  2. What is the most likely source of sepsis?
  3. What is your IMMEDIATE next step in this OPD?
  4. What investigations would you order?
  5. Would you discharge him on oral antibiotics? Why or why not?

CASE 2 - Ward Scenario

A 52-year-old woman admitted 3 days ago for elective cholecystectomy. Post-op Day 2, the nurse calls you at 2 AM: "Doctor, she has a fever of 39.2°C, her BP dropped to 96/60, heart rate 108, and she seems drowsy."
Questions:
  1. What are your first three actions in the next 5 minutes?
  2. What sepsis criteria does she meet?
  3. What is the most likely source?
  4. Write the antibiotic order for her.
  5. When do you call for ICU transfer?

CASE 3 - ICU Scenario

A 70-year-old man is in your ICU on Day 3 of septic shock from pneumonia. He is on:
  • Norepinephrine 0.25 mcg/kg/min
  • Ventilator (assist control, Vt 420 mL, IBW 70 kg, FiO₂ 0.6, PEEP 8)
  • Current vitals: MAP 62, HR 104, SpO₂ 91%, urine output 18 mL in last hour
  • Labs: K⁺ 3.1 mEq/L, Creatinine 2.8 (baseline 1.0), Lactate 3.8, Glucose 220 mg/dL, Platelets 62,000
Questions:
  1. Is he meeting hemodynamic goals? What is not at target?
  2. What is his approximate SOFA score for the renal component?
  3. What would you do about his potassium?
  4. What changes would you make to his ventilator?
  5. He develops petechiae and oozing from IV sites. What complication do you suspect and how do you confirm it?

PART 13 - VISUAL SUMMARY (MIND MAP)

                        SEPSIS & SEPTIC SHOCK
                               │
        ┌──────────────────────┼──────────────────────┐
        │                      │                      │
   DEFINITION              DIAGNOSIS              MANAGEMENT
   Sepsis-3:               qSOFA ≥2               LBLAV Bundle
   SOFA ≥2 +               SOFA ≥2                (Hour-1)
   infection               Lactate                │
        │                  Blood cx               ├─ Fluids: LR 30mL/kg
   Septic Shock:           POCUS                  ├─ Antibiotics <1h
   +vasopressors +                                ├─ NE vasopressor
   lactate >2                                     ├─ Source control
        │                                         └─ Steroids if needed
        │
   COMPLICATIONS
   ├─ Early: ARDS, AKI, DIC, Septic cardiomyopathy
   └─ Late: PICS, ICUAW, CKD, PTSD
        │
   MONITORING
   ├─ MAP ≥65, UO ≥0.5 mL/kg/h
   ├─ Lactate clearance
   ├─ ScvO₂ ≥70%
   └─ SOFA daily

SAFETY DISCLAIMER

Educational Use Only. This content is for learning purposes. All clinical decisions - including antibiotic selection, vasopressor dosing, fluid management, and ICU admission - must be made by a qualified, licensed physician with full knowledge of the patient's clinical status. Drug doses given are standard references; always verify against current formularies and local protocols before prescribing.

Ready for Case-Based Learning? Reply with your answers to Case 1 (the OPD scenario) and I'll provide feedback, guide your reasoning, and progressively reveal the management. Or tell me which specific section you'd like me to go deeper on - electrolytes, mechanical ventilation, DIC management, or any other aspect.

My topic is malaria disease from basics to clinical

Finding Sources
Searching PubMed

"malaria"[MeSH Terms] AND "treatment"[MeSH Terms]

Searching the Web

WHO malaria treatment guidelines 2023 2024 summary artemisinin

Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Reading File
Loading Image
That's your complete malaria module. Here's what's been covered:
18 Sections including:
  • Complete life cycle with annotated diagram (Robbins Pathology)
  • All 5 species compared in a single table with distinguishing blood film features
  • Pathophysiology - exactly WHY each complication occurs (PfEMP1, cytoadherence, rosetting, cytokine storm)
  • WHO severe malaria criteria with the "CAPS RHAHHH" mnemonic
  • Complete treatment tables - ACT regimens, severe malaria artesunate dosing, special populations
  • Full ICU protocol with hourly monitoring parameters
  • OPD → Ward → ED → ICU protocols
  • WHO 2025 guidelines + CDC 2024 guidelines incorporated
  • 3 Case-based scenarios (OPD, Ward, ICU) with questions for you to reason through

Ready to test your knowledge? Reply with your answers to any of the three cases - I'll give you detailed feedback and guide your clinical reasoning. Or tell me which part you want to go deeper on:
  • Mechanisms of drug action (how artemisinin works, why chloroquine fails)
  • Malaria and G6PD deficiency in detail
  • Blackwater fever management
  • Antimalarial resistance - current crisis
  • Malaria vs. other tropical fevers (differential diagnosis)
  • Prescription writing for a specific scenario
This is a shared conversation. Sign in to Orris to start your own chat.